Wipro Receives Best IT Consultancy in Healthcare & Life Sciences, & Product Innovation Award 2016 from Global Health & Pharma

Bangalore, India, and East Brunswick, New Jersey, USA : Wipro Limited, (NYSE: WIT, BSE: 507685, NSE: WIPRO) a leading global information technology, consulting and business process services company, today announced that it has been recognized with two awards by Global Health & Pharma, a leading publication and information sharing platform, dedicated to the healthcare domain. Wipro was recognized as the Best Global Healthcare and Life Sciences IT Consultancy & Outsourcing Company 2016 and won the Product Innovation Award for Wipro 360 Digital Patient Centricity Solution Suite at the 2016 International Life Sciences Awards. The International Life Sciences Awards seek to recognize visionary firms and individuals for harnessing disruptive ideas, which will drive the industry forward. 

Wipro is focused on creating a truly connected health experience that is patient-centric, intuitive, coordinated and personalized, along with building a differentiated global healthcare practice, dedicated to transforming the customer’s journey, enabling them to change the way healthcare is delivered.

Wipro was able to demonstrate the ability to craft and deliver on the promise of a connected health experience. We have invested in new-age early-stage ventures to empower our clients to deliver value-based care focused on preserving wellness and not just managing diseases. By implementing Wipro’s Patient Centricity Suite, healthcare providers are able to empower their patients with health information so they are more involved in the decision-making of their well-being and are able to experience connected healthcare through a collaborative care platform.

Jeffery Heenan Jalil, Sr. Vice President & Global Head, Healthcare, Life Sciences & Services , Wipro Limited said, “We are dedicated to helping our clients change the lives of millions of people every day by enabling them to build breakthrough business models that drive better health and transform healthcare delivery. This award is a recognition of our relentless focus to develop a thoughtful and patient-centric connected health experience across payers, providers, e-health and government funded programs, bio-pharmaceutical and medical device companies.”

About Wipro Limited.

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading information technology, consulting and business process services company that delivers solutions to enable its clients do business better. Wipro delivers winning business outcomes through its deep industry experience and a 360 degree view of “Business through Technology.” By combining digital strategy, customer centric design, advanced analytics and product engineering approach, Wipro helps its clients create successful and adaptive businesses. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, Wipro has a dedicated workforce of over 170,000, serving clients across 6 continents. For more information, please visit www.wipro.com

Media Contact:

Shraboni Banerjee
Wipro Limited
shraboni.banerjee@wipro.com

Forward-looking and Cautionary Statements  

Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov . We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf. 

Tags:

Subscribe

Quotes

This award is a recognition of our relentless focus to develop a thoughtful and patient-centric connected health experience across payers, providers, e-health and government funded programs, bio-pharmaceutical and medical device companies
Jeffery Heenan Jalil, Sr. Vice President & Global Head, Healthcare, Life Sciences & Services, Wipro Limited